Japanese drugmaker Takeda is gearing up to launch its tetravalent dengue vaccine, Qdenga, in India. The vaccine will be ...

Dengue fever, caused by a flavivirus named DENV, is a major global health challenge, risking almost half of the world's ...

Takeda plans to launch its dengue vaccine, Qdenga, in India by next year, partnering with Biological E to support the 'Make-in-India' initiative. The company will employ a tiered pricing model to ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration ...